학술논문
Outcomes of relapse in patients with deferred autologous stem cell transplant after achieving at least very good partial response following bortezomib, adriamycin, dexamethasone chemotherapy for newly diagnosed multiple myeloma in the phase II PADIMAC trial
Document Type
Letter
Author
Chan, W.Y.; Roddie, C.; Rabin, N.; Popat, R.; Yong, K.L.; Counsell, N.; Phillips, E.H.; Adedayo, T.; Braganca, N.; Clifton-Hadley, L.; de Tute, R.; Owen, R.G.; De-Silva, D.; Cavenagh, J.; Streetly, M.; Schey, S.; Koh, M.B.C.; Crowe, J.; Morris, T.C.; Cook, G.; D’Sa, S.; Virchis, A.; Quinn, M.; Crawley, C.; Pratt, G.; Cook, M.
Source
In: British Journal of Haematology . (British Journal of Haematology, February 2022, 196(4):e33-e37)
Subject
Language
English
ISSN
13652141
00071048
00071048